|
ACHV
|
Achieve Life Sciences, Inc.
|
US
|
NASDAQ
|
|
ARAV
|
Aravive, Inc.
|
US
|
NASDAQ
|
|
ATOS
|
Atossa Genetics Inc.
|
US
|
NASDAQ
|
|
AVEO
|
AVEO Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
US
|
NASDAQ
|
|
BCTX
|
BriaCell Therapeutics Corp.
|
US
|
NASDAQ
|
|
BIOC
|
Biocept, Inc.
|
US
|
NASDAQ
|
|
BNR
|
Burning Rock Biotech Limited
|
US
|
NASDAQ
|
|
BOLT
|
Bolt Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
BPTH
|
Bio-Path Holdings Inc
|
US
|
NASDAQ
|
|
CHRS
|
Coherus BioSciences, Inc.
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CLVS
|
Clovis Oncology, Inc.
|
US
|
NASDAQ
|
|
CNTX
|
Context Therapeutics Inc.
|
US
|
NASDAQ
|
|
CRIS
|
Curis, Inc.
|
US
|
NASDAQ
|
|
CTIC
|
Cell Therapeutics, Inc.
|
US
|
NASDAQ
|
|
EFTR
|
eFFECTOR Therapeutics, Inc.
|
US
|
NASDAQ
|
|
GENE
|
Genetic Technologies Ltd
|
US
|
NASDAQ
|
|
GLSI
|
Greenwich LifeSciences, Inc.
|
US
|
NASDAQ
|
|
GTHX
|
G1 Therapeutics, Inc.
|
US
|
NASDAQ
|